Information Disclosure (2022)

I. Basic information

Company Name: Nanjing Chang Ao Pharmaceutical Co, Limited

Organization Code：91320100634081762H

Legal Representative: Xue Xiaobing

Production Address: 63, Kexin Road, Jiangbei New District, Nanjing

Tel：025-68161001

Main contents, products and scale of production, operation and management services:

① Drug development, production (operated according to the matters listed in the provincial drug production license); sales of self-produced products; road transport of general goods (permission or approval is required for operation). (Any project that needs to be approved by law can only be carried out after getting approval by relevant authorities.)

② 25,000,000 capsules/year for diclofenac sodium sustained-release capsules, 54,000,000 tablets/year for irbesartan tablets, 21,600,000 tablets/year for domperidone maleate tablets, 20,000,000 vials/year for rabeprazole sodium for injection, 100,000 tubes/year for diclofenac sodium gel, and 900,000 tubes/year for ofloxacin gel.

II. Drainage information
Wastewater: 2 outlets (wastewater outlet GX-WS-01 and rainwater outlet YS-001). The pollution factors involved are as follows: COD, ammonia nitrogen, pH, total phosphorus, suspended solids, five-day biochemical oxygen demand, total nitrogen, petroleum, animal and vegetable oils, total organic carbon, and acute toxicity. Exhaust gas: 3 outlets (FQ-02, FQ-04). The pollution factors involved are as follows: ozone concentration, ammonia, hydrogen sulfide, ethanol, total volatile organic compounds, particulate matter, and non-methane total hydrocarbons. No total amount of exhaust gas is allowed

III. Construction and operation of pollution prevention facilities

The company currently has 1 wastewater treatment system and 3 exhaust gastreatment facilities, all in normal operation.

Canteen wastewater is processed by grease trap and then treated withdomestic sewage by septic tank, and then treated with equipment cleaning water,process wastewater, etc. by plant inland buried sewage treatment facilities(sedimentation tank + anaerobic tank + contact oxidation tank + secondarysedimentation tank) to reach the wastewater connection standards for largeplants and then connect the sewage treatment plant in the park.

The particulate matters generated from drying and coating are treated bybag-type dust collector; ethanol, non-methane total hydrocarbon and total VOCsare treated by scrubber tower and activated carbon adsorption (including FQ-02for scrubber tower + activated carbon adsorption treatment and FQ-03/04 forscrubber tower treatment) to meet the requirements of Emission Standard of Air Pollutants for Pharmaceutical Industry (GB37823-2019) as well as EIA and approval.
IV. EIA of construction projects and other administrative permits forenvironmental protection

V. Contingency plans for environmental emergenciesAccording to the provisions of the emission permit, our company only needsto fill in the annual emission permit implementation report (see Appendix:Implementation Report)

VII. Other environmental information to be disclosed

None